Loading organizations...
Deep End Partners is a venture capital firm deploying capital into companies within the nascent psychedelic ecosystem. It supports enterprises developing novel therapeutic approaches and research in this emerging health and wellness sector. Their strategic investments foster innovation, particularly in mental health solutions utilizing psychedelic compounds.
Established in 2020, Deep End Partners formed from a strategic insight into the evolving landscape and therapeutic potential of psychedelics. The firm capitalized on increasing scientific interest and shifting regulatory environments. Its inception aimed to back promising ventures positioned to lead this impactful, emergent industry.
Deep End Partners backs early-stage companies and entrepreneurs advancing applications within the psychedelic space. The firm envisions a future where psychedelic-assisted therapies and related innovations integrate into mainstream healthcare. Its objective is to accelerate the industry's growth, facilitating broader access to transformative treatments.
Deep End Partners has 1 tracked investment across 1 company. The latest tracked deal is $4.3M Other Equity / Seed in Maya Health in December 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 17, 2021 | Maya Health | $4.3M Other Equity / Seed | BEK Nurgazy, Henri Sant Cassia | Cosmo Feilding Mellen, Craig Nerenberg, Heather Jackson, Mark Zittman, Meyer Mishkin, Michael Blitzer, Noah Levy, Ambria Capital, Aquanta Group, BWC Group, Heather Jackson Revocable Trust, KP Investment Partners, MA Financial, Mark A. Zittman Revocable Trust, Nicholas Henry Moryl Revocable Trust, Psynergia Labs, Rinat Family 2006 Trust |
